MACULAR CHOROIDAL NEOVASCULARIZATION IN PERIPAPILLARY HYPERREFLECTIVE OVOID MASS-LIKE STRUCTURES: CASE REPORT.

Retin Cases Brief RepOct 28, 2026
Case ReportOphthalmologyRadiology (Diagnostic)

Ana Bárbara Dias Lopes Urzedo, Kenzo Hokazono

✦ AI-curated · Sources linked

Case in brief

A healthy 36-year-old woman presented with three days of vision loss in her right eye. Optical coherence tomography of the optic nerve head showed peripapillary hyperreflective ovoid mass-like structures (PHOMS), while macular OCT angiography demonstrated type 2 choroidal neovascularization. After an intravitreal anti-VEGF injection, her condition improved markedly.

What made this case unusual

The notable finding was the coexistence of macular type 2 choroidal neovascularization with PHOMS, an association the report describes as rare.

Diagnostic / clinical pearl

When PHOMS are seen on optic nerve head OCT, assess the macula as well; in this case, OCT angiography identified associated type 2 choroidal neovascularization.

Source

PubMed · PMID 42351330

Published in Retin Cases Brief Rep. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Ophthalmology

Clinical ResearchVascular SurgeryOpen access

Revascularization of Asymptomatic Carotid Artery Stenosis: Cognitive Results of the CREST-2 Randomized Trials.

This prespecified cognitive-outcomes analysis of the multicentre, randomised CREST-2 trials assessed patients aged 35 years or older with at least 70% asymptomatic carotid stenosis.

JAMAOct 27, 2026Read summary
Clinical ResearchObstetrics & GynecologyOpen access

Intrauterine Mepivacaine Instillation vs Placebo for Pain During IUD Placement: A Randomized Clinical Trial.

This multicentre, double-blind, randomised, placebo-controlled trial tested intrauterine mepivacaine before IUD placement in nulliparous individuals aged 18 to 31 years at 11 Swedish clinics.

JAMAOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.